{"date":"2025-07-20","count":2,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6612-2025-07-20-2213-13t4weh","company_id":"6612","company":"奈米醫材","market":"上櫃","industry":"生技醫療","date":"2025-07-20","time":"22:13:40","subject":"美國子公司人工水晶體產品通過歐盟醫療器材法規MDR認證","clause":"第53款","fact_date":"2025-07-19","cite_as":"公開資訊觀測站重大訊息：奈米醫材（6612），2025-07-20 22:13，「美國子公司人工水晶體產品通過歐盟醫療器材法規MDR認證」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6564-2025-07-20-1200-evmhgy","company_id":"6564","company":"安特羅","market":"興櫃","industry":"生技醫療","date":"2025-07-20","time":"12:00:39","subject":"公告本公司向越南藥政主管機關Drug Administration ofVietnam(DAV)提交腸病毒71型疫苗新藥查驗登記審核(NDA)","clause":"第44款","fact_date":"2025-07-18","cite_as":"公開資訊觀測站重大訊息：安特羅（6564），2025-07-20 12:00，「公告本公司向越南藥政主管機關Drug Administration ofVietnam(DAV)提交腸病毒71型疫苗新藥」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}